Education

How To Use TipRanks TipRanks Labs Webinar Center Glossary FAQs

About Us

About TipRanks Contact Us Careers Reviews Mobile APP

Working with TipRanks

Enterprise Solutions Top Online Brokers Become an Affiliate

News Trending Portfolio

TOOLS

Top Smart Score Stocks

STOCKS

Best High Yield Dividend Stocks

Dividend Aristocrats

Dividend Stock Comparison

New

Dividend Calculator

Dividend Returns Comparison

Dividend Calendar

Top Analysts

Top Financial Bloggers

Top-Performing Corporate Insiders

Top Hedge Fund Managers

Top Research Firms

Top Individual Investors

News

Portfolio

Personal Finance Center

Mortgages

Loans

Investing & Retirement

Spending & Savings

Calculators

Compound Interest Calculator

Student Loan Calculator

401k Retirement Calculator

Education

About Us

Working with TipRanks

Enterprise Solutions

Top Online Brokers

Become an Affiliate

Vicore Pharma Holding AB (DE:6Y4)

FRANKFURT:6Y4

6Y4

Vicore Pharma Holding AB

RESEARCH TOOLS

Top Smart Score Stocks

Stock Screener

reports

Vicore Pharma Holding AB (6Y4) Income Statement

2 Followers

Vicore Pharma Holding AB Income Statement

Last quarter (Q4 2022), Vicore Pharma Holding AB's total revenue was kr0.00, a decrease of ― from the same quarter last year. In Q4, Vicore Pharma Holding AB's net income was kr-60.70M. See Vicore Pharma Holding AB’s key income statements, including revenue, expenses, profit, and income.

Income Statement	TTM	Dec 22	Dec 21	Dec 20	Dec 19	Dec 18
Total Revenue	-	kr 0.00	kr 0.00	kr 0.00	kr 0.00	kr 508.00K
Cost of Revenue	-	-	-	-	-	-
Gross Profit	-	kr 0.00	kr 0.00	kr 0.00	kr 0.00	-
Operating Expense	kr 287.49M	kr 287.49M	kr 293.42M	kr 149.47M	kr 93.92M	kr 42.09M
Operating Income	kr -287.49M	kr -287.49M	kr -293.42M	kr -149.47M	kr -93.92M	kr -41.59M
Net Non Operating Interest Income Expense	kr 905.00K	kr 905.00K	kr 635.00K	kr 809.00K	kr 136.00K	kr -352.00K
Other Income Expense	-	-	-	-	-	-
Pretax Income	kr -288.81M	kr -288.81M	kr -296.74M	kr -147.31M	kr -93.33M	kr -21.68M
Tax Provision	kr -384.00K	kr -384.00K	kr -254.00K	kr -453.00K	kr -245.00K	kr 0.00
Earnings From Equity Interest Net Of Tax	-	-	-	-	-	-
Net Income Common Stockholders	kr -288.42M	kr -288.42M	kr -296.48M	kr -146.86M	kr -93.08M	kr -21.68M
Basic EPS	-	-	-	-	-	-
Diluted EPS	-	-	-	-	-	-
Basic Average Shares	-	-	-	-	-	-
Diluted Average Shares	-	-	-	-	-	-
Dividend Per Share	-	-	-	-	-	-
Total Operating Income As Reported	-	-	-	-	-	-
Reported Normalized Basic E P S	-	-	-	-	-	-
Reported Normalized Diluted E P S	-	-	-	-	-	-
Rent Expense Supplemental	-	-	-	-	-	-
Total Expenses	kr 287.49M	kr 287.49M	kr 293.42M	kr 149.47M	kr 93.92M	kr 42.09M
Net Income From Continuing And Discontinued Operation	kr -288.42M	kr -288.42M	kr -296.48M	kr -146.86M	kr -93.08M	kr -21.68M
Normalized Income	kr -288.42M	kr -289.44M	kr -294.36M	kr -148.28M	kr -93.63M	kr -25.36M
Interest Expense	kr 2.13M	kr 8.00K	kr 11.00K	kr 6.00K	kr 27.00K	kr 352.00K
EBIT	kr -286.68M	kr -288.80M	kr -296.72M	kr -147.31M	kr -93.30M	kr -21.33M
EBITDA	kr -286.68M	kr -285.19M	kr -293.13M	kr -143.77M	kr -91.96M	kr -21.32M

Currency in SEK

Vicore Pharma Holding AB Earnings and Revenue History

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing